Journal
BIOMEDICAL CHROMATOGRAPHY
Volume 33, Issue 6, Pages -Publisher
WILEY
DOI: 10.1002/bmc.4491
Keywords
dried blood spot; enasidenib; LC-MS; MS; method validation; mouse blood; pharmacokinetics
Ask authors/readers for more resources
A simple, sensitive and rapid assay method has been developed and validated as per regulatory guidelines for the estimation of enasidenib on mouse dried blood spots (DBS) using liquid chromatography coupled to tandem mass spectrometry with electrospray ionization in the positive-ion mode. The method employs liquid extraction of enasidenib from DBS disks of mouse whole blood followed by chromatographic separation using 0.2% formic acid-acetonitrile (25:75, v/v) at a flow rate of 1.0 mL/min on an Atlantis dC(18) column with a total run time of 2.0 min. The MS/MS ion transitions monitored were m/z 474.0 -> 267.1 for enasidenib and m/z 309.2 -> 251.3 for the internal standard (warfarin). The assay was linear in the range of 1.01-3044 ng/mL. The within-run and between-run precisions were in the range of 3.18-9.06 and 4.66-8.69%, respectively. Stability studies showed that enasidenib was stable on DBS cards for 1 month. This novel method has been applied to analyze the DBS samples of enasidenib obtained from a pharmacokinetic study in mice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available